Lipodystrophic syndromes:: congenital or acquired diseases of adipose tissue.

被引:8
作者
Capeau, Jacqueline
Vigouroux, Corinne
Magre, Jocelyne
Lascols, Olivier
Caron, Martine
Bastard, Jean-Philippe
机构
[1] Univ Paris 06, Inserm U680, Fac Med, F-75571 Paris 12, France
[2] Hop Tenon, APHP, Serv Biochim, F-75970 Paris 20, France
关键词
lipodystrophy; genetic or acquired diseases; alterations of lipid and glucose metabolism; insulin resistance; metabolic syndrome; hypercorticism; HIV antiretroviral treatment;
D O I
10.1016/j.crvi.2005.11.008
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Lipodystrophic syndromes regroup a heterogeneous group of genetic or acquired diseases. Lipodystrophy, an altered development and/or repartition of body fat, is associated with alterations of lipid and glucose metabolism with insulin resistance. Genetic forms, rare, can be generalized and recessive resulting from mutations in the seipin or AGPAT2 gene. Partial lipodystrophies are dominant and observed in patients mutated in the gene encoding PPAR-gamma or lamin A/C, a gene seen also mutated in patients with syndromes of premature aging. Acquired forms are common and regroup the highly prevalent Metabolic Syndrome, hypercorticism together with lipodystrophy related to antiretroviral treatment of HIV-infected patients.
引用
收藏
页码:639 / 652
页数:14
相关论文
共 49 条
[1]   AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34 [J].
Agarwal, AK ;
Arioglu, E ;
de Almeida, S ;
Akkoc, N ;
Taylor, SI ;
Bowcock, AM ;
Barnes, RI ;
Garg, A .
NATURE GENETICS, 2002, 31 (01) :21-23
[2]   The metabolic syndrome - a new worldwide definition [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
LANCET, 2005, 366 (9491) :1059-1062
[3]   Normal reproductive function in leptin-deficient patients with lipoatropic diabetes [J].
Andreelli, F ;
Hanaire-Broutin, H ;
Laville, M ;
Tauber, JP ;
Riou, JP ;
Thivolet, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (02) :715-719
[4]   Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension [J].
Barroso, I ;
Gurnell, M ;
Crowley, VEF ;
Agostini, M ;
Schwabe, JW ;
Soos, MA ;
Maslen, GL ;
Williams, TDM ;
Lewis, H ;
Schafer, AJ ;
Chatterjee, VKK ;
O'Rahilly, S .
NATURE, 1999, 402 (6764) :880-883
[5]   Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance [J].
Bastard, JP ;
Caron, M ;
Vidal, H ;
Jan, V ;
Auclair, M ;
Vigouroux, C ;
Luboinski, J ;
Laville, M ;
Malachi, M ;
Girard, PM ;
Rozenbaum, W ;
Levan, P ;
Capeau, J .
LANCET, 2002, 359 (9311) :1026-1031
[6]   Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy [J].
Bonne, G ;
Di Barletta, MR ;
Varnous, S ;
Bécane, HM ;
Hammouda, EH ;
Merlini, L ;
Muntoni, F ;
Greenberg, CR ;
Gary, F ;
Urtizberea, JA ;
Duboc, D ;
Fardeau, M ;
Toniolo, D ;
Schwartz, K .
NATURE GENETICS, 1999, 21 (03) :285-288
[7]   Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy [J].
Cao, H ;
Hegele, RA .
HUMAN MOLECULAR GENETICS, 2000, 9 (01) :109-112
[8]   The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro [J].
Caron, M ;
Auclair, M ;
Lagathu, C ;
Lombès, A ;
Walker, UA ;
Kornprobst, M ;
Capeau, J .
AIDS, 2004, 18 (16) :2127-2136
[9]   Some HIV protease inhibitors alter lamin A/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation [J].
Caron, M ;
Auclair, M ;
Sterlingot, H ;
Kornprobst, M ;
Capeau, J .
AIDS, 2003, 17 (17) :2437-2444
[10]   The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance [J].
Caron, M ;
Auclair, R ;
Vigouroux, C ;
Glorian, M ;
Forest, C ;
Capeau, J .
DIABETES, 2001, 50 (06) :1378-1388